Responses
Other responses
Jump to comment:
- Published on: 23 November 2015
- Published on: 23 November 2015
- Published on: 23 November 2015Author's replyShow More
Dear Editor,
I have read the letter from Professor Walley and colleagues with interest. I have no desire to restate my editorial but would have the following comments.
Comments such as “data is virtually complete”, “only two patients underwent a second revascularisation in another north-west NHS hospital” and the low diabetes rates “are probably due to ethnicity differences” reflect all the problems of a...
Conflict of Interest:
None declared. - Published on: 23 November 2015Are drug eluting stents worth the money?Show More
Dear Editor,
We wish to respond to criticisms of our paper on the cost effectiveness of drug eluting stents (DES) by Martyn Thomas in his recent editorial.
The criticisms are that:
• Our study is based on data of uncertain quality from one centre, which may be biased, and report unusually low rates of diabetes and revascularisation.
Processes of validation of our data are available on req...
Conflict of Interest:
None declared.